Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Colloids and Surfaces. B, Biointerfaces|August 3, 2022
A novel carbon-nanodots-based theranostic nano-drug delivery system for mitochondria-targeted imaging and glutathione-activated delivering camptothecinXiaojuan Gong, Zihan Wang, Li Zhang, et al.Frontiers in Public Health|May 8, 2025
Development of a questionnaire to evaluate the management of gestational diabetes mellitus patients among obstetric nursesYongyan Zhu, Yumin Ren, Jing Ma, et al.Biochemical Pharmacology|August 14, 2016
Chemotherapy enhances tumor vascularization via Notch signaling-mediated formation of tumor-derived endothelium in breast cancerPeng Zhang, Dongxu He, Zhen Chen, et al.Oncology Reports|June 29, 2013
Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cellsFangfang Du, Xiaohong Wu, Yanjun Liu, et al.Oncology Letters|October 24, 2022
Erratum: A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell propertiesXiaofeng Han, Fangfang Du, Li Jiang, et al.Oncology Letters|November 2, 2013
A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell propertiesXiaofeng Han, Fangfang DU, Li Jiang, et al.Mabs|June 25, 2026
Discovery and optimization of a pH-responsive ultra-long-acting VHH-based growth hormone mimeticHoucong Jin, Gao Sun, Hongxia Shen, et al.Frontiers in Immunology|June 12, 2024
Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE studyJosep M Llibre, Judith A Aberg, Sharon Walmsley, et al.Antimicrobial Agents and Chemotherapy|May 3, 2022
Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1Margaret Gartland, Pedro Cahn, Edwin DeJesus, et al.Pageof 5